Evidence map›Paper›PMID 30607081›Full record

ArticleEthiopian journal of health sciences2018

Abdissa Biruksew, Ahmed Zeynudin, Yonas Alemu, Lemu Golassa, Moti Yohannes, Asfaw Debella, Geme Urge, Bart De Spiegeleer, Sultan Suleman

Abstract read
In one paragraph

Article in Ethiopian journal of health sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Potentials ofInfection and drug resistance · 2023
    Review
  8. Medicinal plants as a fight against murine blood-stage malaria.Saudi journal of biological sciences · 2021
    Review
  9. Review
  10. The GenusFrontiers in pharmacology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abdissa BiruksewSchool of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma Institute of Health, Jimma University, Ethiopia.
Ahmed ZeynudinSchool of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma Institute of Health, Jimma University, Ethiopia.
Yonas AlemuSchool of Medical Laboratory Sciences, Faculty of Health Sciences, Jimma Institute of Health, Jimma University, Ethiopia.
Lemu GolassaAklilu Lemma Institute of Pathobiology, Addis Ababa University.
Moti YohannesSchool of Veterinary Medicine, Jimma University, Ethiopia.
Asfaw DebellaDepartment of Traditional and Modern Drug Research, Ethiopia.
Geme Urge305 Pennshire Dr Lancaster, USA.
Bart De SpiegeleerDrug Quality and Registration (DruQuaR) group, Faculty of Pharmaceutical Sciences, Ghent University, Belgium.
Sultan SulemanSchool of Pharmacy, Faculty of Health Sciences, Jimma Institute of Health, Jimma University, Jimma, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe emergence and spread of Plasmodium falciparum resistance to antimalarial drugs necessitated the search for new drugs from natural products. Zingiber officinal Roscoe and Echinops Kebericho Mesfin are traditional herbal medicines widely used for the treatment of malaria in Ethiopia. The aim of the study was to assess the toxicity profile and in vivo antiplasmodial activities of 70% methanol crude extracts of both plant materials against Plasmodium berghei.

methodsHealthy male Swiss Albino mice of age 4-5 weeks and weight 25-36 g were infected by P. berghei. The extracts were administered orally at doses 5000, 2500 and 1250 mg/kg for acute toxicity of E. kebericho Mesfin. Graded doses at 1000, 500 and 250 mg/kg used for four days suppressive studies. Parasitemia, body weight, packed cell volume (PCV) and survival time were determined. SPSS Version 20 was used for the analysis of data of parasitemia, body weight, PCV, and survival times. Statistical significance was determined by one-way ANOVA. Independent t-test was used to compare results. Results were presented as a mean ± standard error of the mean (M ± SEM). All data were analyzed at a 95% confidence interval (α= 0.05).

resultsAt the dose of 5000 mg/kg, E. kebericho Mesfin showed no toxic effects. The LD50 of extract could go beyond the dose used. In vivo antiplasmodial activity of extracts showed excellent chemo suppression at 500 and 1000 mg/kg in a dose dependent manner compared with the negative control. The chemo suppressions of the 1000 mg/kg of both plant extracts were 49.53 ± 1.90% and 32.83 ± 1.03%, respectively. The survival times of P. berghei infected mice were also a dose dependent manner while failed to prevent weight loss.

conclusionThe extracts of both medicinal plants showed antiplasmodial activities against P. berghei. It confirmed the literature findings and their traditional uses.

Indexed as

AsteraceaeZingiber officinaleAnimalsAntimalarialsDose-Response Relationship, DrugEthiopiaMaleMiceMice, Inbred StrainsParasitemiaPhytotherapyPlant ExtractsPlasmodium bergheiAntimalarialsPlant ExtractsantiplasmodialEchnops kebericho Mesfinoral acute toxicityPlasmodium bergheiZengibir officinale Roscoe

Identifiers

PMID30607081
PMCPMC6308778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.